Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II studyEvaluation of patients with clinically detected recurrence of rectal carcinoma: Current practice patterns of colorectal surgeons

  • Authors:
    • Ankur Sangoi
    • Uday Patel
    • Kenichi Ode
    • Riccardo Audisio
    • Katherine S. Virgo
    • Frank E. Johnson
  • View Affiliations

  • Published online on: March 1, 2010     https://doi.org/10.3892/ol_00000063
  • Pages: 355-359
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The optimal evaluation of patients with clinically suspected recurrence of rectal carcinoma following initial treatment has yet to be determined. We documented the intensity of the extent-of-disease workup conducted by colorectal surgeons when their patients with rectal carcinoma develop clinical evidence of metastases. A custom-designed questionnaire was mailed to all 1,795 members of the American Society of Colon and Rectal Surgeons. Subjects were asked which laboratory tests and imaging studies they would order for one of their own generally healthy patients with a suspicious abnormality found during surveillance testing. The tests most frequently recommended were computed tomography and serum carcinoembryonic antigen level. Few tests were recommended by >90% of respondents. There is no consensus among experts in this common situation.
View References

Related Articles

Journal Cover

March-April 2010
Volume 1 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sangoi A, Patel U, Ode K, Audisio R, Virgo KS and Johnson FE: Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II studyEvaluation of patients with clinically detected recurrence of rectal carcinoma: Current practice patterns of colorectal surgeons . Oncol Lett 1: 355-359, 2010.
APA
Sangoi, A., Patel, U., Ode, K., Audisio, R., Virgo, K.S., & Johnson, F.E. (2010). Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II studyEvaluation of patients with clinically detected recurrence of rectal carcinoma: Current practice patterns of colorectal surgeons . Oncology Letters, 1, 355-359. https://doi.org/10.3892/ol_00000063
MLA
Sangoi, A., Patel, U., Ode, K., Audisio, R., Virgo, K. S., Johnson, F. E."Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II studyEvaluation of patients with clinically detected recurrence of rectal carcinoma: Current practice patterns of colorectal surgeons ". Oncology Letters 1.2 (2010): 355-359.
Chicago
Sangoi, A., Patel, U., Ode, K., Audisio, R., Virgo, K. S., Johnson, F. E."Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II studyEvaluation of patients with clinically detected recurrence of rectal carcinoma: Current practice patterns of colorectal surgeons ". Oncology Letters 1, no. 2 (2010): 355-359. https://doi.org/10.3892/ol_00000063